Drugmaker Sanofi has addressed all the manufacturing deficiencies at the French plant where its new, promising rheumatoid arthritis treatment will be produced, Chief Executive Olivier Brandicourt said.
from WSJ.com: US Business http://ift.tt/2kSfp7J
via IFTTT
No comments:
Post a Comment